Archives


Research Article

Year : 2019 | Volume: 4 | Issue: 1 | Pages: 64-70

Synthesis and anticancer activity of glycol-bridged bis-benzimidazoles\n

Bernhard Biersack1*, Abdellatif El-Kihel, Said Jebbari, Mustapha Ahbala, Houssine Ait Sir, Florian Schmitt, Madeleine Gold, Patrick Bauchat, Rainer Schobert2

https://dx.doi.org/doi:10.18831/djchem.org/110

Corresponding author

Bernhard Biersack*

Organische Chemie 1, Universitat Bayreuth, Universitatsstrasse 30, 95447 Bayreuth, Germany.

  • 1. Organische Chemie 1, Universitat Bayreuth, Universitatsstrasse 30, 95447 Bayreuth, Germany.

Received on: 2019/02/26

Revised on: 2019/02/15

Accepted on: 2019/03/26

Published on: 2019/04/04

  • Synthesis and anticancer activity of glycol-bridged bis-benzimidazoles\n, Bernhard Biersack, Abdellatif El-Kihel, Said Jebbari, Mustapha Ahbala, Houssine Ait Sir, Florian Schmitt, Madeleine Gold, Patrick Bauchat, Rainer Schobert 2019/04/04, DJ Journal of Engineering Chemistry and Fuel, 4(1), 64-70, https://dx.doi.org/doi:10.18831/djchem.org/110.

    Published on: 2019/04/04

Abstract

A series of bis-benzimidazoles with polyglycol-sulfide linker were prepared and tested for their tumor cell growth inhibitory activities. Two derivatives (2c and 3a) showed significant growth inhibitory activities against 518A2 melanoma cells. In addition, these compounds were active against multidrug resistant KB-V1Vbl cervix carcinoma cells (vinblastine-resistant cells with overexpressed P-gp transporter) and MCF-7Topo breast carcinoma cells (topotecan-resistant cells with overexpressed BCRP transporter). Thus, we have identified valuable lead structures for the design of new anticancer drugs based on benzimidazole systems that can overcome drug resistance.

Keywords

Anticancer drugs, Benzimidazole, Glycol, Multidrug resistance, Thioether.